These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6527105)
1. Diagnostic sensitivity, diagnostic specificity and predictive value of the determination of tumour markers. Wagener C J Clin Chem Clin Biochem; 1984 Dec; 22(12):969-79. PubMed ID: 6527105 [TBL] [Abstract][Full Text] [Related]
2. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Ebert W; Muley T; Drings P Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537 [TBL] [Abstract][Full Text] [Related]
3. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer]. Lahousen M Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273 [TBL] [Abstract][Full Text] [Related]
5. Use of the preoperative levels of CEA in patients with colorectal cancer. Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969 [TBL] [Abstract][Full Text] [Related]
6. Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients. Gion M; Peloso L; Mione R; Vignati G; Fortunato A; Saracchini S; Biasioli R; Gulisano M; Cappelli G Cancer J; 2001; 7(3):181-90. PubMed ID: 11419026 [TBL] [Abstract][Full Text] [Related]
7. [Oncofetal proteins - their character and clinical significance as tumour-markers (author's transl)]. Ziegenbein R Zentralbl Chir; 1980; 105(23):1537-45. PubMed ID: 6163265 [TBL] [Abstract][Full Text] [Related]
8. Serial determination of CEA and CA 15.3 in breast cancer follow-up: an assessment of their diagnostic accuracy for the detection of tumour recurrences. Mariani L; Miceli R; Michilin S; Gion M Biomarkers; 2009 Mar; 14(2):130-6. PubMed ID: 19330591 [TBL] [Abstract][Full Text] [Related]
9. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536 [TBL] [Abstract][Full Text] [Related]
10. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318 [TBL] [Abstract][Full Text] [Related]
11. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D; Nürnberg R; Bahlo M; Klapdor R Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival. Kasimir-Bauer S; Schleucher N; Weber R; Neumann R; Seeber S Oncol Rep; 2003; 10(2):475-82. PubMed ID: 12579292 [TBL] [Abstract][Full Text] [Related]
14. Methodological aspects of the evaluation of postoperative cancer surveillance. Part I: Validity. Abel U; Wollermann C Clin Lab; 2003; 49(7-8):367-77. PubMed ID: 12908736 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Godfrey TE; Raja S; Finkelstein SD; Gooding WE; Kelly LA; Luketich JD Clin Cancer Res; 2001 Dec; 7(12):4041-8. PubMed ID: 11751499 [TBL] [Abstract][Full Text] [Related]
16. Multiple tumour markers for diagnosis, management and follow-up of potentially resectable lung cancer. Ratto GB; Mereu C; Rovida S Panminerva Med; 1993 Dec; 35(4):186-92. PubMed ID: 8202329 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084 [TBL] [Abstract][Full Text] [Related]
18. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value]. Villani C Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207 [TBL] [Abstract][Full Text] [Related]
19. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients. Garbe C; Leiter U; Ellwanger U; Blaheta HJ; Meier F; Rassner G; Schittek B Cancer; 2003 Apr; 97(7):1737-45. PubMed ID: 12655531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]